Logo
Login

Company Executives

$ Management Team

Dr. Burt Adelman

Independent Chairman of the Board

Age 71
Compensation $451.9K USD
Sex Male

Mr. Andrew Ashe

President

Chief Operating Officer

General Counsel

Age 57
Compensation $3.319M USD
Sex Male

Dr. Sekar Kathiresan

Chief Executive Officer

Director

Age 52
Compensation $9.320M USD
Sex Male

Ms. Allison Dorval

Chief Financial Officer

Age 48
Compensation $3.485M USD
Sex Female

Ms. Joan Nickerson

Chief Administrative Officer

Age 56
Compensation -
Sex Female

Dr. Troy Lister

Chief Scientific Officer

Age -
Compensation -
Sex Male

Dr. Frederick Fiedorek

Chief Medical Officer

Age 69
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 25, 2025
Directors
9
serving now
Independent
7 of 9
stated in the proxy
Average tenure
4.0 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2024 pay Source
Lonnel Coats
60 2022
3 years
 Independent
Audit
Blueprint Medicines Corporation $521,499
Jodie Morrison
49 2024
1 year
 Independent
Compensation Research and development
None stated $964,970
Krishna Yeshwant
46 2018
7 years
 Independent
Nominating and corporate governance
None stated $522,667
Alexander Cumbo
54 2022
3 years
 Independent
Compensation
Climb Bio, Inc. $521,499
Michael MacLean
59 2021
4 years
 Independent
Audit · Chair
None stated $533,999
Sheila Mikhail
58 2021
4 years
 Independent
Audit Nominating and corporate governance
None stated $526,499
Burt Adelman
72 2018
7 years
 Independent
Compensation · Chair Nominating and corporate governance · Chair Research and development
Clear Creek Bio, Inc. $568,999
Sekar Kathiresan
CEO
 53 2019
6 years
 Not independent None stated Relay Therapeutics, Inc., Maze Therapeutics, Inc. Paid as CEO
Ourania "Nia" Tatsis
55 2024
1 year
 Not independent
Research and development · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 25, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans